Small manufacturing systems to produce research grade pharmaceutical intermediates-diversity on demand- sbir phase 1 topic 024
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95024C00023
- Awardee
-
On Demand Pharmaceuticals Inc. UEI SN3RFJHJ2GP3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $325,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20241 · Posted Jul 7, 2023
- Contract value 100% obligated
- $325,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to On Demand Pharmaceuticals Inc. The contract is for the development of small manufacturing systems to produce research-grade pharmaceutical intermediates, under SBIR Topic 024. The contract is a firm-fixed-price definitive contract with a ceiling value of $325,000.00 and an ultimate completion date of June 23, 2025. The contract was set aside for small businesses.
Quick answers
Who was awarded contract 75N95024C00023?
75N95024C00023 was awarded to On Demand Pharmaceuticals Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2024.
How much is contract 75N95024C00023 worth?
The government has obligated $325,000 on 75N95024C00023.
Which agency awarded contract 75N95024C00023?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024C00023, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95024C00023 competed?
The extent of competition for 75N95024C00023 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award